Skip to main content
AmigoFish

Episode 504: ASCO 2026 - ADC Drug Development in Urothelial Cancer

From The Uromigos · · 40 min

This plays from the publisher's own server. We do not host a copy.

Open at the source

Not rated yet

Description

This episode with Gopa Iyer from MSKCC explores the latest advances in antibody drug conjugates (ADCs) in urothelial cancer, including data from EV302, novel ADCs targeting Nectin-4, and sequencing strategies. Experts discuss efficacy, safety, biomarkers, and future directions in bladder cancer treatment.

Back to The Uromigos · Report a problem